The Valley Desk

NCT00306592 · Interventional trial

Natalizumab Re-Initiation of Dosing

Overall registry status Completed

Phase 3

Conditions Multiple Sclerosis, Relapsing-Remitting

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov